Medical Condition News

RSS

Antibodies targeting GPNMB may slow Parkinson's disease progression

Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson's disease (PD).

12 May 2026

Intensive caregiving may accelerate cognitive decline

Onerous caring responsibilities reduce brain function for people aged 50 and over, whereas light caring duties can actually be beneficial to middle-aged and older people's mental abilities, a new UCL study finds.

12 May 2026

Cannabis and tobacco co-use may increase psychosis risk

A new multisite study published in Nature Mental Health found that using cannabis and tobacco together increases the risk of developing psychotic disorders like schizophrenia among those considered high risk.

12 May 2026

Scientists develop advanced lab-grown kidney organoids for disease research

A team led by USC Stem Cell scientist Zhongwei Li, PhD, has produced some of the most complex and mature lab-grown kidney models to date.

12 May 2026

AI-powered handheld microscope may improve early cancer detection

Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer.

12 May 2026

Researchers uncover nuclear organization mechanism linked to Friedreich's ataxia

Researchers have uncovered a fundamental rule that governs how genes are physically arranged inside the cell nucleus, and how disruptions to that organization can contribute to human disease.

12 May 2026

Large human islet study reveals new insights into diabetes risk

Diabetes is the most common and serious chronic disease worldwide, characterized by insufficient insulin to maintain proper blood glucose levels.

12 May 2026

Interactive AI model improves explainable lung cancer diagnosis from CT scans

Lung cancer remains one of the leading causes of cancer-related deaths worldwide, making early and accurate diagnosis essential for improving patient outcomes.

12 May 2026

Could GLP-1 drugs help breast cancer patients live longer?

A large retrospective cohort study of adult female breast cancer patients found that GLP-1 receptor agonist use was associated with better all-cause survival and recurrence-free survival in patients with obesity or type 2 diabetes. The strongest associations were seen versus non-use in obesity and versus insulin or metformin in type 2 diabetes, while comparisons with SGLT2 inhibitors were less consistent and require further study.

12 May 2026

How diabetes could drain $5 trillion from the global economy by 2050

A macroeconomic modelling study across 190 countries and territories estimates that diabetes could reduce global economic output by INT$5.177 trillion between 2021 and 2050. Most projected losses stem from diabetes-related disability and morbidity, with high-income countries facing the largest dollar losses and low- and middle-income countries carrying most of the disease burden.

12 May 2026

Why older adults are turning to edible cannabis for sleep, pain, and mood

Older adults in Colorado were drawn to edible cannabis mainly to manage sleep problems, pain, anxiety, or depression, often after concerns about conventional medicines or limited relief from other treatments. Most participants preferred THC-CBD combination products, but they remained uncertain about dosing, impairment, effectiveness, and how to choose the right cannabinoid ratio.

12 May 2026

New antibody therapy promotes nerve regeneration after spinal cord injury

An international research group recently demonstrated that the antibody NG101 promotes the regeneration of damaged spinal cord tissue.

12 May 2026

Cedars-Sinai develops AI tool for faster and cheaper tumor analysis

A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes expressed in cancerous tumors.

12 May 2026

Using AI to improve success rates of fecal microbiota transplants

MOZAIC leverages deep learning to optimize fecal microbiota transplantation, enhancing treatment efficacy through precise donor-recipient microbiome matching.

12 May 2026

Cannabis compounds may improve metabolism and reduce diabetes risk

A University of California, Riverside preclinical study is shedding light on a long-observed but poorly understood phenomenon: chronic cannabis users tend to have lower body weight and a reduced risk of developing type 2 diabetes, despite the drug's well-known tendency to increase appetite.

11 May 2026

Gene mapping highlights strong immune and brain connections in depression

Neurons and white blood cells differ greatly in shape, function, and location within the body. However, researchers at the University of São Paulo (USP) in Brazil discovered that certain genes are equally dysregulated in both cell types in people with depression.

11 May 2026

New AI chip identifies meibomian gland dysfunction within milliseconds

A research team from Peking Union Medical College Hospital and Tsinghua University has developed a compact optical AI chip that can identify meibomian gland dysfunction (MGD)-a major cause of dry eye disease-with more than 96% accuracy by analyzing the tissue's spectral signatures.

11 May 2026

Why are so many mothers missing diabetes follow-up after childbirth?

A New York City cohort study found that few women with postpartum-onset diabetes received guideline-recommended A1C monitoring over three years. Non-Hispanic Black women and mothers with more children faced lower monitoring rates, while Medicaid coverage was linked to better follow-up.

11 May 2026

Two leading heart risk tools pass a major global test

A multinational Nature Medicine validation study found that PREVENT and SCORE2 cardiovascular risk equations performed generally well across 6.4 million people from observational cohorts and randomized trials. The findings support broader use of these tools for CVD risk stratification, while highlighting the need for local calibration and more validation in underrepresented regions.

11 May 2026

Study links metabolic dysfunction to cognitive impairment in bipolar disorder

While they share similar depressive and cognitive symptoms, the biological underpinnings of bipolar disorder and major depressive disorder are distinct.

11 May 2026